EFFECT OF DURALABHADI LEHA(AN AYURVEDIC MEDICINE ) AND INDRAVARUNIKADI CHURNA (AN AYURVEDIC MEDICINE) IN ASTHMA.

A COMPARATIVE CLINICAL STUDY OF DURALABHADI LEHA AND INDRAVARUNIKADI CHURNA IN THE MANAGEMENT OF TAMAK SHWASA WITH SPECIAL REFERENCE TO PRINCIPLE à¤¤à¤®à¤?à¥? à¤¤à¥? à¤µà¤¿à¤°à¥?à¤?à¤¨à¤®(à¤?.à¤?à¤¿. 17/121)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035798

Enrollment

Registered

2021-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Ages ranging from 18 years to 60 years. Those ready to give written informed consent. Patient present with sign and symptom of Tamak shwasa. Eligible patient able to participate for 8 weeks.

Exclusion criteria

Exclusion criteria: Patients with severe bronchial asthma. Patients present with associated morbid disorder.(TB etc.) Patient with poorly controlled hypertension (i.e. systolic >160 mm of HG and diastolic >100 mm of HG) Pregnancy or lactating women. Patients with alcohol dependence. H/o Hypersensitivity to the trial drugs or any of its ingredients. Patient with evidence of malignancy. Symptomatic patient with clinical evidence of heart failure.

Design outcomes

Primary

Measure	Time frame
Change in the clinical symptoms ofTamak shwasa. 1.Shwasakrichhta (Dyspnoea) 2.Peenasa ( Nasal discharge) 3.Kasa (Cough) 4.Kapha nishatheevana (Expectoration) 5.Ghurghurakam shabda (Wheezing) 6.Urahshoola (Chest pain)Timepoint: 60 days	—

Secondary

Measure	Time frame
1. Change in the laboratory parameters. 2. FrequencyTimepoint: 60 days	—

Countries

India

Contacts

Public ContactSushil Kumar Kaswan

National Institute of Ayurveda

guptadr.nisha@gmail.com9828087640

Outcome results